FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
This intro examines risk profiles for index vs target date funds, offering a clear take on volatility, diversification, and potential drawdowns.
24,893 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
House Democrats introduced the Death Bets Act to outlaw prediction markets tied to war outcomes and fatalities amid o...
NVIDIA leads the Magnificent 7 in March with a 1.7% gain through Friday, while Apple and Tesla retreat as investors r...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
Strategy, the software firm formerly known as MicroStrategy, reported a $12.77 billion first-quarter loss as Bitcoin ...
Bitcoin trades near $82,000 as trump’s ceo-filled china visit becomes a live test for the market’s risk-on rally. A c...
With winter looming, Ryanair faces higher jet fuel costs. The airline’s CFO says contingency plans are in place as fu...
A nationwide labor crunch is tightening the screws on U.S. construction as immigrant workers pull back amid policy ch...
JPMorgan argues a bold AI productivity push—the moonshot to avoid trillion national debt—could avert a looming $39 tr...
A new Los Angeles exhibit invites you to look beyond the iconic white dress and pink gowns. This personal-finance fri...
Retail investors are retreating from crypto while institutions step up exposure, reshaping liquidity and risk. The sh...
SpaceX gears up for the largest IPO in history on Nasdaq, while a 1:1 tokenized SpaceX equity trades on Solana. Backp...